Key Points
Med1 controls T cell differentiation and survival during acute bacterial infection.
Med1 deficiency in T cells impairs T-bet–mediated transcriptional programs.
C/EBPβ promotes T-bet expression by interacting with Med1 in effector T cells.
Abstract
Effector CD8+ T cells are crucial players in adaptive immunity for effective protection against invading pathogens. The regulatory mechanisms underlying CD8+ T cell effector differentiation are incompletely understood. In this study, we defined a critical role of mediator complex subunit 1 (Med1) in controlling effector CD8+ T cell differentiation and survival during acute bacterial infection. Mice with Med1-deficient CD8+ T cells exhibited significantly impaired expansion with evidently reduced killer cell lectin-like receptor G1+ terminally differentiated and Ly6c+ effector cell populations. Moreover, Med1 deficiency led to enhanced cell apoptosis and expression of multiple inhibitory receptors (programmed cell death 1, T cell Ig and mucin domain–containing-3, and T cell immunoreceptor with Ig and ITIM domains). RNA-sequencing analysis revealed that T-bet– and Zeb2-mediated transcriptional programs were impaired in Med1-deficient CD8+ T cells. Overexpression of T-bet could rescue the differentiation and survival of Med1-deficient CD8+ effector T cells. Mechanistically, the transcription factor C/EBPβ promoted T-bet expression through interacting with Med1 in effector T cells. Collectively, our findings revealed a novel role of Med1 in regulating effector CD8+ T cell differentiation and survival in response to bacterial infection.
Footnotes
This work was supported by a Major International (Regional) Joint Research Programme Project grant (81820108017 to B.Z.), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81771673 to B.Z.), the National Natural Science Foundation of China (3217080356 to B.Z.), and the Natural Science Foundation of Shaanxi Province (2020JQ-098 to L.L.).
The online version of this article contains supplemental material.
- Received January 11, 2022.
- Accepted June 25, 2022.
- Copyright © 2022 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.